Genetic control of interleukin 12 responsiveness: Implications for disease pathogenesis

Journal of Molecular Medicine

Volumn 75, Issue 7, 1997, Pages 502-511

  Gorham, James D ^a   Güler, Mehmet L ^a   Murphy, Kenneth M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy; Autoimmunity; Genetics; Interleukin 12; Leishmania; T helper 1 T helper 2

Indexed keywords

INTERLEUKIN 12;

ATOPY; AUTOIMMUNITY; CHROMOSOME 5Q; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; IMMUNOREGULATION; INFECTION RISK; LEISHMANIASIS; MOUSE; NONHUMAN; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12;

EID: 0030871759     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050135     Document Type: Review

References (100)

1. Kay AB (1994) T cells, cytokines and asthma. J R Coll Physicians Lond 28:325-331
2. Liblau RS, Singer SM, McDevitt HO (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38
3. O'Garra A, Murphy K (1993) T-cell subsets in autoimmunity. Curr Opin Immunol 5:880-886
4. Kline JN, Hunninghake GW (1994) T-lymphocyte dysregulation in asthma. Proc Soc Exp Biol Med 207:243-253
5. Güler ML, Gorham JD, Hsieh C, Mackey AJ, Steen RG, Dietrich WF, Murphy KM (1996) Genetic susceptibility to Leishmania: IL-12 responsiveness in determining TH1 cell development. Science 271:984-987
6. Gorham JD, Güler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM (1996) Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 93:12467-12472
7. Seder RA, Paul WE (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells. Ann Rev Immunol 12:635-673
8. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of T helper lymphocytes. Nature 383:787-793
9. Seder RA, Gazzinelli R, Sher A, Paul WE (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90:10188-10192
10. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220
11. Hsieh C-S, Heimberger AB, Gold JS, O'Garra A, Murphy KM (1992) Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha-beta-T-cell-receptor transgenic system. Proc Nat Acad Sci USA 89:6065-6069
12. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-mduced macrophages. Science 260:547-549
13. Tripp CS, Wolf SF, Unanue ER (1993) Interleukin 12 and tumor necrosis factor alpha are co-stimulators of Interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Nat Acad Sci USA 90:3725-3729
14. Reiner SL, Zheng S, Wang Z-E, Stowring L, Locksley RM (1994) Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells curing initiation of infection. J Exp Med 179:447-456
15. Yoshimoto T, Paul WE (1994) CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179:1285-1295
16. Schmilz J, Thiel A, Kuhn R, Rajewsky K, Muller W, Assenmacher M, Radbruch A (1994) Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J Exp Med 179:1349-1353
17. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Ann Rev Immunol 13:151-177
18. Howard JG (1986) Immunological regulation and control of experimental leishmaniasis. Int Rev Exp Pathol 28:79-116
19. Heinzel FP, Sadick MD, Mutha SS, Locksley RM (1991) Production of interferon-gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Nat Acad Sci USA 88:7011-7015
20. Scott P (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous Leishmaniasis. J Immunol 147:3149-3155
21. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237
22. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM (1990) Cure of murine leishmaniasis with antiinterleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171:115-127
23. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509
24. Sypek JP, Chung CL, Mayor SEH, Subramanyam, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous Leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802
25. Reiner SL, Wang Z-E, Hatam F, Scott P, Locksley RM (1993) Th1 and Th2 cell antigen receptors in experimental Leishmaniasis. Science 259:1457-1460
26. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL (1996) Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183:515-526
27. Nathan CF, Hibbs JB Jr (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65
28. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER (1993) Release of nitric oxide during the T cell-independent pathway of macrophage activation. J Immunol 150:888-895
29. Green SJ, Meltzer MS, Hibbs Jr JB, Nacy CA (1990) Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144:278-283
30. Liew FY, Millott S, Parkinson C, Palmer RMJ, Moncada S (1990) Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 144:4794-4797
31. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM (1995) T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 181:713-721
32. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM (1995) Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665-675
33. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U (1996) A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA 93:14002-14007
34. Wu CY, Warrier RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PK, Stern AS, Gubler U, Presky DH et al (1996) Biological function and distribution of human interleukin-12 receptor beta chain. Eur J Immunol 26:345-350
35. Chua AO, Wilkinson VL, Presky DH, Gubler U (1995) Cloning and characterization of a mouse IL-12 receptor-beta component. J Immunol 155:4286-4294
36. Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA (1995) Interleukin 12 (IL-12) induces tyrosine phosphorylation of Jak2 and TYK2: differential use of janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 181:399-404
37. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM (1995) Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (STAT)3 and Stat4. J Exp Med 181:1755-1762
38. Bacon CM, Petricoin EF, 3rd, Ortaldo JR, Rees RC, Earner AC, Johnston, JA, O'Shea JJ (1995) Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA 92:7307-7311
39. Kaplan MH, Sun YL, Hoey T, Grusby MJ (1996) Impaired IL12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177
40. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC et al (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174
41. Szabo SJ, Dighe AS, Gubler U, Murphy KM (1997) Regulation of the IL-12R β2 subunit in developing Th1 and Th2 cells. J Exp Med 185:817-824
42. Yanagida T, Kato T, Igarashi O, Inoue T, Nariuchi H (1994) Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J Immunol 152:4919-4928
43. Dietrich WF, Miller JC, Steen RG, Merchant M, Damron D, Nahf R, Gross A, Joyce DC, Wessel M, Dredge RD et al (1994) A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat Genet 7:220-245
44. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
45. Wilson SD, Billings PR, D'Eustachio P, Fournier RE, Geissler E, Lalley PA, Burd PR, Housman DE, Taylor BA, Dorf ME (1990) Clustering of cytokine genes on mouse chromosome 11. J Exp Med 171:1301-1314
46. Lossie AC, MacPhee M, Buchberg AM, Camper SA (1994) Mouse chromosome 11. Mammalian Genome 5 Spec No: S164-180
47. Mock B, Blackwell J, Hilgers J, Potter M (1993) Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogenet 20:335-348
48. Demant P, Lipoldova M, Svobodova M (1996) Resistance to Leishmania major in Mice. Science 274:1392
49. Shankar AH, Titus RG (1995) T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 181:845-855
50. Gieni RS, Fang Y, Trinchieri G, Umetsu DT, DeKruyff RH (1996) Differential production of IL-12 in BALB/c and DBA/2 mice controls IL-4 versus IFN-gamma synthesis in primed CD4 lymphocytes. Int Immunol 8:1511-1520
51. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Schou C, Beaty TH (1995) Genetic basis of IgE responsiveness: relevance to the atopic diseases. Int Arch Allergy Immunol 107:25-28
52. Huang SK, Yi M, Kumai M, Marsh DG (1994) Immunogenetic aspects of IgE-mediated responses. Adv Exp Med Biol 347:11-16
53. Kay AB (1991) T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 94:189-193
54. Vercelli D, Jabara HH, Geha RS (1989) Regulation of human IgE synthesis. Int Rev Immunol 5:111-115
55. Koike M, Takatsu K (1994) IL-5 and its receptor: which role do they play in the immune response? Int Arch Allergy Immunol 104:1-9
56. Terada N, Konno A, Togawa K (1994) Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 94:629-642
57. Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S (1991) Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 88:4538-4542
58. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR (1993) Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bron-choalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 92:313-324
59. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298-304
60. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152-1156
61. Meyers DA, Postma DS, Panhuysen CI, Xu J, Amelung PJ, Levitt RC, Bleecker ER (1994) Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23:464-470
62. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, Meyers DA, Levitt RC (1995) Genetic susceptibility to asthma-bronchial hyperresponsiveness coin-herited with a major gene for atopy. N Engl J Med 333:894-900
63. De Sanctis GT, Merchant M, Beier DR, Dredge RD, Grobholz JK, Martin, TR, Lander ES, Drazen JM (1995) Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BE/6J mice. Nat Genet 11:150-154
64. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Souef PN, Lathrop GM et al (1996) A genome-wide search for quantitative trait loci underlying asthma. Nature 383:247-250
65. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155:111-117
66. Hilkens CMU, Messer G, Tesselaer K, van Rietschoten AGI, Kapsenberg ML, Wierenga EA (1996) Eack of IL-12 signaling in human allergen-specific Th2 cells. J Immunol 157:4316-4321
67. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM, Hieny S, Caspar P, Sher A (1994) Anti-IL-4 treatment of Schistosoma mansoni-mfected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153:753-759
68. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A (1994) Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179:1551-1561
69. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A (1995) An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-596
70. Araujo MI, de Jesus AR, Bacellar O, Sabin E, Pearce E, Carvalho EM (1996) Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 26:1399-1403
71. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ (1996) Impairment of tetanus toxoid-specific Thl-like immune responses in humans infected with Schistosoma mansoni. J Infectious Diseases 173:269-272
72. Maizels RM, Bundy DA, Selkirk ME, Smith DF, Anderson RM (1993) Immunological modulation and evasion by helminth parasites in human populations. Nature 365:797-805
73. Locksley RM (1994) Th2 cells: help for helminths. J Exp Med 179:1405-1407
74. Couissinier-Paris P, Dessein AJ (1995) Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur J Immunol 25:2295-2302
75. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ (1991) Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 21:2679-2686
76. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349:243-245
77. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ (1993) Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infectious Diseases 168:1000-1008
78. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, Weissenbach J, Dessein AJ (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 14:181-184
79. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT (1996) Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 97:1402-1408
80. Swanborg RH (1995) Exp autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77:4-13
81. Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1-17
82. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM (1992) Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Nat Acad Sci USA 89:574-578
83. Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176:1355-1364
84. Sundvall M, Jirholt J, Yang HT, Jansson L, Engstrom A, Pettersson U, Holmdahl R (1995) Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 10:313-317
85. Baker D, Rosenwasser OA, O'Neill JK, Turk JL (1995) Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 155:4046-4051
86. Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L (1996) A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet 13:477-480
87. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W et al (1996) A full genome search in multiple sclerosis. Nat Genet 13:472-476
88. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genetics 13:469-471
89. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genetics 13:464-468
90. Haskins K, McDuffie M (1990) Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249:1433-1436
91. Haskins K, Portas M, Bradley B, Wegmann D, Eafferty K (1988) T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444-1448
92. Katz JD, Wang B, Haskins K, Benoist C, Mathis D (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089-1100
93. Katz JD, Benoist C, Mathis D (1995) T helper cells subsets in insulin-dependent diabetes. Science 268:1185-1188
94. Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y et al (1996) Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2:1348-1353
95. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight, AM, Love JM, McAleer MA et al (1991) Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351:542-547
96. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-82
97. Yule TD, Tung KS (1993) Exp autoimmune orchitis induced by testis and sperm antigen-specific T cell clones: an important pathogenic cytokine is tumor necrosis factor. Endocrinology 133:1098-1107
98. Meeker ND, Hickey WF, Korngold R, Hansen WK, Sudweeks JD, Wardell BB, Griffith JS, Teuscher C (1995) Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci USA 92:5684-5688
99. Seder RA, Kelsall BL, Jankovic D (1996) Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 157:2745-2748
100. Vyse TJ, Todd JA (1996) Genetic analysis of autoimmune disease. Cell 85:311-318